Do you have to taper off Wegovy when you stop?

There is no pharmacological taper, but that does not mean stopping is simple

Some medicines require a gradual dose reduction because stopping suddenly disrupts the body's own chemistry. Wegovy is not one of them. Semaglutide works by activating GLP-1 receptors to reduce appetite and slow gastric emptying; once you stop taking it, the drug clears your system over a few weeks, and those receptors simply return to their baseline state. No rebound surge, no withdrawal syndrome.

That is the pharmacology. The practical reality is different. The appetite suppression that made the medicine effective disappears with it. Studies consistently show that people who stop semaglutide regain a significant proportion of the weight they lost within one to two years, unless robust diet and activity habits have taken hold in the meantime. The NHS medicines page for semaglutide frames Wegovy as a long-term treatment for a chronic condition, not a short course, for exactly this reason.

So the decision is not really about whether a taper is medically needed. It is about whether stopping is the right choice at this point, and what support sits alongside it if you do.

Three situations where stopping comes up, and what each one calls for

Most people face this decision for one of three reasons: cost, a planned break (surgery, pregnancy planning, a holiday where refrigeration is impractical), or a feeling that they have reached their goal and want to see if they can maintain without the medicine.

Cost is the most common. If price is the driver, it is worth understanding exactly what a private treatment plan includes before deciding, the Wegovy pricing page sets out what legitimate treatment actually covers, including clinical oversight and aftercare. Sometimes people pause unnecessarily because they assume costs are fixed, when a conversation with a prescriber about dose or timing might resolve things differently.

For a planned break (surgery, travel without reliable cold storage, a pause before trying to conceive) giving your prescriber advance notice matters. They can advise on timing, note it in your record, and plan the restart. If you are pausing for a holiday, the practical guide to stopping Wegovy covers storage and what to expect on resumption.

If you feel ready to stop permanently after reaching your goal, that is a legitimate decision. But the evidence strongly favours having a maintenance plan in place first, not as a condition of stopping, but because the months immediately after stopping are when appetite tends to return with the most force.

What to expect in the weeks after your last dose

Semaglutide has a half-life of roughly one week, which means meaningful drug levels persist for three to five weeks after the final injection. Many people notice little change initially. Then, gradually, food becomes more appealing again, portions feel less satisfying, and the mental quieting of food noise that the medicine provided starts to lift.

This is not a failure of willpower. It is biology reasserting itself, and it is worth being prepared for rather than surprised by. People who do best after stopping are typically those who have used the treatment period to build sustainable habits (regular meals, adequate protein, consistent movement) rather than relying solely on appetite suppression.

The NHS England guidance on weight-management injections is clear that these medicines work best alongside behavioural support, and that applies particularly to the period after stopping. If you are wondering whether you need to taper off Wegovy before stopping, or if you are asking whether you have to wean off Wegovy gradually, both questions are worth exploring before your final dose. If you are wondering whether staying on Wegovy longer is the right call, the guidance on long-term use sets out what the evidence says.

How a prescriber approaches the stopping decision

Under NICE guidance for semaglutide, if a patient achieves less than 5% weight loss after six months on the full maintenance dose, continuing is reviewed. That is one defined stopping point. Outside of that, when to stop is a clinical conversation, not a hard rule.

A prescriber reviewing your case will think about how much weight you have lost, how stable that loss has been, what your original health goals were, whether those conditions (blood pressure, sleep apnoea, blood sugar) have improved, and what your plan looks like without the medicine. It is a short conversation, but an important one. If you are already treated through a clinician-led service like ours, that conversation is part of what aftercare means, not a chargeable extra.

If you have not yet started treatment and are weighing up Wegovy as an option, our prescribers review every consultation the same day. You can start your free consultation here and get a clear answer on whether Wegovy is appropriate for you.